Decreased motivation during chronic pain requires long-term depression in the nucleus accumbens

Science

Volumn 345, Issue 6196, 2014, Pages 535-542

  Schwartz, Neil ^a   Temkin, Paul ^a   Jurado, Sandra ^a,b   Lim, Byung Kook ^a,c   Heifets, Boris D ^a   Polepalli, Jai S ^a   Malenka, Robert C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALANIN; GALANIN RECEPTOR 1;

FATIGUE; LONG-TERM CHANGE; NEUROLOGY; PATHOLOGY; RODENT; SYMPTOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CHRONIC PAIN; CONTROLLED STUDY; DEPRESSION; HIPPOCAMPUS; LONG TERM DEPRESSION; MOTIVATION; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; GENE SILENCING; GENETICS; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ANIMALS; CHRONIC PAIN; DISEASE MODELS, ANIMAL; GENE KNOCKDOWN TECHNIQUES; LONG-TERM SYNAPTIC DEPRESSION; MALE; MICE; MICE, INBRED C57BL; MOTIVATION; NUCLEUS ACCUMBENS; RECEPTOR, GALANIN, TYPE 1;

EID: 84905909423     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1253994     Document Type: Article

References (48)

1. B. Nicholson, S. Verma, Pain Med. 5, S9-S27 (2004).
2. D. C. Turk, J. Audette, R. M. Levy, S. C. Mackey, S. Stanos, Mayo Clin. Proc. 85, S42-S50 (2010).
3. J. Dersh, P. B. Polatin, R. J. Gatchel, Psychosom. Med. 64, 773-786 (2002).
4. T. Jonsson et al., Acta Anaesthesiol. Scand. 55, 69-74 (2011).
5. J. P. Johansen, H. L. Fields, B. H. Manning, Proc. Natl. Acad. Sci. U.S.A. 98, 8077-8082 (2001).
6. D. Borsook et al., Eur. J. Pain 11, 7-20 (2007).
7. C. A. von Hehn, R. Baron, C. J. Woolf, Neuron 73, 638-652 (2012).
8. A. I. Basbaum, D. M. Bautista, G. Scherrer, D. Julius, Cell 139, 267-284 (2009).
9. J. D. Salamone, M. Correa, Neuron 76, 470-485 (2012).
10. G. J. Mogenson, D. L. Jones, C. Y. Yim, Prog. Neurobiol. 14, 69-97 (1980).
11. B. W. Balleine, J. P. O'Doherty, Neuropsychopharmacology 35, 48-69 (2010).
12. D. J. Scott, M. M. Heitzeg, R. A. Koeppe, C. S. Stohler, J.-K. Zubieta, J. Neurosci. 26, 10789- 10795 (2006).
13. M. N. Baliki et al., Nat. Neurosci. 15, 1117-1119 (2012).
14. R. Urban, G. Scherrer, E. H. Goulding, L. H. Tecott, A. I. Basbaum, Pain 152, 990-1000 (2011).
15. I. Yalcin et al., Biol. Psychiatry 70, 946-953 (2011).
16. H. S. Roane, J. Appl. Behav. Anal. 41, 155-161 (2008).
17. C. P. O'Brien, E. L. Gardner, Pharmacol. Ther. 108, 18-58 (2005).
18. J. A. Shuen, M. Chen, B. Gloss, N. Calakos, J. Neurosci. 28, 2681-2685 (2008).
19. A. Sanz-Clemente, R. A. Nicoll, K. W. Roche, Neuroscientist 19, 62-75 (2013).
20. B. R. Lee, Y. Dong, Neuropharmacology 61, 1060-1069 (2011).
21. M. B. Max et al., Mol. Pain 2, 14 (2006).
22. P. G. Unschuld et al., J. Affect. Disord. 105, 177-184 (2008).
23. N. R. Wray et al., Mol. Psychiatry 17, 36-48 (2012).
24. Y. S. Nikolova, E. K. Singhi, E. M. Drabant, A. R. Hariri, Genes Brain Behav. 12, 516-524 (2013).
25. M. E. Anderson, J. Runesson, I. Saar, U. Langel, J. K. Robinson, Behav. Brain Res. 239, 90-93 (2013).
26. V. Sergeyev, C. Broberger, T. Hökfelt, Brain Res. Mol. Brain Res. 90, 93-100 (2001).
27. H. Imbe et al., Neurosci. Lett. 368, 102-106 (2004).
28. H. Nishii, M. Nomura, H. Aono, N. Fujimoto, T. Matsumoto, Regul. Pept. 141, 105-112 (2007).
29. X.-L. Gu, Y.-G. Sun, L.-C. Yu, Behav. Brain Res. 179, 331-335 (2007).
30. B. K. Lim, K. W. Huang, B. A. Grueter, P. E. Rothwell, R. C. Malenka, Nature 487, 183-189 (2012).
31. Y. Dong, J. P. Tyszkiewicz, T. M. Fong, J. Neurophysiol. 95, 3228-3234 (2006).
32. E. B. Einstein, Y. Asaka, M. F. Yeckel, M. J. Higley, M. R. Picciotto, Eur. J. Neurosci. 37, 1541- 1549 (2013).
33. E. J. Cobos et al., Pain 153, 876-884 (2012).
34. K. Yashiro, B. D. Philpot, Neuropharmacology 55, 1081- 1094 (2008).
35. P. F. Durieux et al., Nat. Neurosci. 12, 393-395 (2009).
36. S. Jurado, V. Biou, R. C. Malenka, Nat. Neurosci. 13, 1053-1055 (2010).
37. S. M. Nicola, J. Neurosci. 30, 16585-16600 (2010).
38. A. M. Farrar et al., Neuroscience 166, 1056-1067 (2010).
39. J. L. Santerre et al., Pharmacol. Biochem. Behav. 102, 477-487 (2012).
40. M. K. Lobo, E. J. Nestler, Front. Neuroanat. 5, 41 (2011).
41. J. C. Lemos et al., Nature 490, 402-406 (2012).
42. B. B. Land et al., J. Neurosci. 28, 407-414 (2008).
43. G. Dölen, A. Darvishzadeh, K. W. Huang, R. C. Malenka, Nature 501, 179-184 (2013).
44. M. Marinelli, P. V. Piazza, Eur. J. Neurosci. 16, 387- 394 (2002).
45. G. Cui et al., Nature 494, 238-242 (2013).
46. F. Kasanetz et al., Science 328, 1709-1712 (2010).
47. A. Chaudhuri, P. O. Behan, Lancet 363, 978- 988 (2004).
48. K. B. Norheim, G. Jonsson, R. Omdal, Rheumatology (Oxford) 50, 1009-1018 (2011).